TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman

Starting soon · Phase 4

Conditions studied: Ischemic Stroke, Acute, Ischemic Stroke

In brief

The goal of this study is to establish and examine the efficacy of using a Telestroke network in Oman to facilitate using emergent thrombolysis for patients with acute ischemic stroke encountered in selected peripheral hospitals. It is proposed to establish a TeleStroke network involving two central hospitals in Muscat linked to three to five peripheral hospitals in Oman which currently have access to CT scans and basic infrastructure for management of AIS patients- but do not have a Neurology service. Selected staff from Internal Medicine/Emergency Medicine departments, Nursing, Technical service and support staffs will be trained in the process of assessment and management of AIS patients including the use of IV alteplase or tenecteplase. They will also be trained in timely access of a Neurologist on call at the central hospital(s) using a TeleStroke network. The Neurologist would conduct a Telestroke based clinical assessment of the AIS patient, review imaging and laboratory results in a timely manner and advice the medical team at the peripheral hospital regarding administration of IV alteplase/tenecteplase. The main purpose of such consultation would be to recognize eligible patients for administration of IV thrombolysis safely at the earliest opportunity within 4.5 hours, leading to increased rates of such thrombolysis with expected improved outcomes. Outcomes would be compared among 100 patients with AIS managed across these 5 hospitals prior to initiation of the practice of thrombolysis and at least 100 patients treated each with IV alteplase using TeleStroke Consultation with Neurologist. Demonstration of efficacy of TeleStroke based stroke thrombolysis would lead to effective implementation of this practice in Oman.

Key facts

Study ID

NCT07721129

Run by

Oman Ministry of Health

People needed

200

Starts

2026-08-01

Expected to finish

2027-03-30

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years. Acute neurologic deficits due to cerebral ischemia/infarction. Clearly defined onset with duration from stroke onset of <4.5 hours. Significant neurological deficit (usually NIHSS score of 4-25).

You may not qualify if…

• CT brain shows showing evidence of intracranial hemorrhage
• CT brain showing acute or subacute infarct of size about >1/3 Middle Cerebral Artery territory.
• Arterial puncture at non compressible site in previous 7 days
• History of previous intracranial hemorrhage.
• Intracranial neoplasm, AV malformation, or aneurysm
• Recent head injury OR intracranial or intraspinal surgery in last 3 mo.
• Persistent Elevated BP >185/110 mm Hg despite treatment.
• Active ongoing internal bleeding.
• Platelet count <100 000/mm3.
• Current use of NOACs OR warfarin with INR >1.7 OR Inj.Enoxaparin/Heparin in therapeutic dose
• Blood glucose concentration <2.7mmol/L (<50mg/dl).
• Relative contraindications: (may consider IV alteplase on individual evaluation).
• Seizure at onset with post ictal residual neurological deficit.
• Signs of mild stroke in isolation or rapidly improving symptoms.
• Pregnancy.
• Recent GI or UT hemorrhage within the last 21 days.
• Recent MI within previous 3 months (to exclude anterolateral infarct / STEMI)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.